ELOCTATE™
ELOCTATE™ [Antihemophilic Factor (Recombinant), Fc Fusion Protein], is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A congenital factor VIII deficiency for:
- On-demand treatment and control of bleeding episodes
- Perioperative management of bleeding
- Routine prophylaxis to reduce the frequency of bleeding episodes
*ELOCTATE™ is not indicated for the treatment of von Willebrand disease.
For indications, dosing and other information, please refer to the prescribing information.
ELOCTATE™ ‐ Biogen
Fully Accredited Distributor
BDI Pharma is a Verified-Accredited Wholesale Distributor and a member of HISCI. Always rest assured your product is being handled with the utmost care and professionalism.
For the FDA Wholesale Distributor License Reporting Site, click here.
Contact Us
1-800-948-9834
BDI Pharma, Inc. Headquarters
120 Research Drive, Columbia, SC, 29203
120 Research Drive, Columbia, SC, 29203
